In contrast, no significant correlation was observed between C1orf50 expression and prognosis in Basal-type (Fig. 1F), Luminal B (Supplementary Fig. 1A), or HER2-type breast cancer patients (Supplementary Fig. 1B). This evidence concerns the gene ERBB2 and breast carcinoma.